jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Biology, Engineering, Medicine and Science ReportsNOW IN
Article

A Brief Report on Utility of N-terminal pro-B-type Natriuretic Peptide (NT-proBNP) in Screening Patients at Risk of Atrial Fibrillation and Stroke

Arun HS Kumar1

  1. 1Stemcology, School of Veterinary Medicine, University College Dublin, Belfield, Dublin, Ireland..

Received: 28-04-2023; Revised: 01-05-2023; Accepted: 02-05-2023.

Volume 9, Issue 2 · pp. 36–39 · PUBLISHED · DOI: 10.5530/bems.9.2.7

View on BEMSR original site ↗

ABSTRACT

N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a prohormone that is produced and released by the heart (ventricles) in response to alteration in pressure/strain/volume. It is used as a biomarker of cardiac function and is involved in the regulation of fluid and electrolyte balance. When the heart is under stress or is experiencing decreased blood flow, the ventricular myocardium releases the precursor molecule proBNP, which is then cleaved (by a membrane-bound enzyme called corin) into B-type natriuretic peptide (BNP) and NT-proBNP in equimolar amounts.

KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Kumar, A. H. (). A Brief Report on Utility of N-terminal pro-B-type Natriuretic Peptide (NT-proBNP) in Screening Patients at Risk of Atrial Fibrillation and Stroke. Biology, Engineering, Medicine and Science Reports, 9(2), 36–39. https://doi.org/10.5530/bems.9.2.7